Innate defense regulator peptide synergizes with CpG ODN for enhanced innate intestinal immune responses in neonate piglets

International Immunopharmacology

Volumn 12, Issue 2, 2012, Pages 415-424

  Yang, Jun ^a   Mao, Miaopeng ^a   Zhang, Shuiqing ^a   Li, Huazhou ^b   Jiang, Zhenggu ^b   Cao, Guangjun ^a   Cao, Ding ^a   Wang, Xingfu ^b   Zhang, Linghua ^a  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^b Swine Seed Breeding Center of Guangzhou   (China)

Author keywords

CpG ODN; Innate defense regulator peptides; Innate intestinal immune responses; Neonatal piglets

Indexed keywords

BETA ACTIN; CPG OLIGODEOXYNUCLEOTIDE; CXCL11 CHEMOKINE; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 12P40; INTERLEUKIN 4; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDE HH2; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTEROTOXIGENIC ESCHERICHIA COLI; IMMUNOMODULATION; IN VIVO STUDY; INNATE IMMUNITY; INTESTINE MUCOSA; MUCOSAL IMMUNITY; NEWBORN; NONHUMAN; PIGLET; PRIORITY JOURNAL; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANIMALS, NEWBORN; CHEMOKINES, CC; CHEMOKINES, CXC; ENTEROTOXIGENIC ESCHERICHIA COLI; IMMUNITY, MUCOSAL; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-4; INTESTINES; LYMPH NODES; OLIGODEOXYRIBONUCLEOTIDES; PEPTIDES; SWINE; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862831894     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.12.015     Document Type: Article

References (45)

1. C.B. Wilson, D.B. Lewis, and B.K. English T cell development in the fetus and neonate Adv Exp Med Biol 310 1991 17 27
2. B. Adkins, C. Leclerc, and S. Marshall-Clarke Neonatal adaptive immunity comes of age Nat Rev Immunol 4 2004 553 564
3. A. Marchant, and M. Goldman T cell-mediated immune responses in human newborns: ready to learn? Clin Exp Immunol 141 2005 10 18
4. A.M. Krieg CpG motifs in bacterial DNA and their immune effects Annu Rev Immunol 20 2002 709 760
5. A.M. Krieg, and M.J. McCluskie Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA Curr Top Microbiol Immunol 311 2006 155 178
6. Q. Cheng, Z.G. Jiang, C.C. Xu, H.Z. Li, D. Cao, and Z.H. Yang CpG oligodeoxynucleotide promotes protective immunity in the enteric mucosa and suppresses enterotoxigenic E. coli in the weaning piglets Int Immunopharmacol 10 2010 1249 1260
7. J.J. Oppenheim, and D. Yang Alarmins: chemotactic activators of immune responses Curr Opin Immunol 17 2005 359 365
8. D.M.E. Bowdish, D.J. Davidson, Y.E. Lau, K. Lee, M.G. Scott, and R.E.W. Hancock Impact of LL-37 on anti-infective immunity J Leukoc Biol 77 2005 451 459
9. F. Niyonsaba, A. Someya, M. Hirata, H. Ogawa, and I. Nagaoka Evaluation of the effects of peptide antibiotics human betadefensins- 1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells Eur J Immunol 31 2001 1066 1075
10. Y.E. Lau, D.M. Bowdish, C. Cosseau, R.E. Hancock, and D.J. Davidson Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37 Am J Respir Cell Mol Biol 34 2006 399 409
11. J. Kindrachuk, H. Jenssen, M. Elliott, R. Townsend, A. Nijnik, and S.F. Lee A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity Vaccine 27 2009 4662 4671
12. C. Schellack, C. Schellack, K. Prinz, A. Egyed, J.H. Fritz, and B. Wittmann IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses Vaccine 24 2006 5461 5472
13. J. Kovacs-Nolan, L. Latimera, A. Landia, H. Jenssenb, R.E.W. Hancockb, and L.A. Babiukc The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice Vaccine 27 2009 2055 2064
14. E. Scrutena, J. Kovacs-Nolan, P.J. Griebel, L. Latimer, J. Kindrachuk, and Andy Potter Retro-inversion enhances the adjuvant and CpG co-adjuvant activity of host defence peptide Bac2A Vaccine 28 2010 2945 2956
15. A.M. Harandi, K. Eriksson, and J. Holmgren A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection J Virol 77 2 2003 953 962
16. A.A. Ashkar, S. Bauer, W.J. Mitchell, J. Vieira, and K.L. Rosenthal Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2 J Virol 77 16 2003 8948 8956
17. A.R. Olbrich, S. Schimmer, K. Heeg, K. Schepers, T.N. Schumacher, and U. Dittmer Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs J Virol 76 22 2002 11397 11404
18. D. Verthelyi, M. Gursel, R.T. Kenney, J.D. Lifson, S. Liu, and J. Mican CpG oligodeoxynucleotides protect normal and SIV-infected macaques from Leishmania infection J Immunol 170 9 2003 4717 4723
19. N.P. Juffermans, J.C. Leemans, S. Florquin, A. Verbon, A.H. Kolk, and P. Speelman CpG oligodeoxynucleotides enhance host defense during murine tuberculosis Infect Immun 70 1 2002 147 152
20. Q. Cheng, C.C. Xu, L.H. Zhang, J.Q. Li, T. Cao, and M.R. Zhang Administered CpG oligodeoxynucleotide induces mRNA expression of CXC and CC chemokines at the intestinal mucosa and PBMCs in piglets Int Immunopharmacol 10 2010 611 618
21. D. Cao, H.Z. Li, Z.G. Jiang, C.C. Xu, Q. Cheng, and Z.H. Yang Synthetic innate defence regulator peptide enhances in-vivo immunostimulatory effects of CpG ODN in newborn piglets Vaccine 28 2010 6006 6013
22. S. Kamstrup, D. Verthelyi, and D.M. Klinman Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides Vet Microbiol 78 2001 353 362
23. C.M. Asmi, A.R. Tassakka, R. Savan, H. Watanuki, and M. Sakai The in vitro effects of CpG oligodeoxynucleotides on the expression of cytokine genes in the common carp (Cyprinus carpio L.) head kidney cells Vet Immunol Immunopathol 110 1-2 2006 79 85
24. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method Methods 25 2001 402 408
25. L.A. Ward, B.I. Rosen, L. Yuan, and L.J. Saif Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs J Gen Virol 77 1996 1431 1441
26. L.H. Zhang, X.S. Tian, and F.Z. Zhou In vivo immunostimulatory effects of CpG ODN in newborn piglets Mol Immunol 44 6 2007 1238 1244
27. G.I. Solano-Aguilar, K.G. Vengroski, E. Beshah, L.W. Douglass, and J.K. Lunney Characterization fo lymphocyte subsets from mucosal tissues in neonatal swine Dev Com Immuno 25 2001 245 263
28. L.H. Zhang, Y. Guo, X.S. Tian, and F.Z. Zhou Co-administration of porcine-specific CpG oligodeoxynucleotide enhances the immune responses to pseudorabies attenuated virus vaccine in newborn piglets in vivo Develop Comp Immunol 30 6 2006 589 596
29. K. Haverson, M. Bailey, V.R. Higgins, P.W. Bland, and C.R. Stokes Characterization ofmonoclonal antibodies specific for monocytes, macrophages and granulocytes from porcine peripheral blood and mucosal tissues J Immunol Methods 170 2 1994 Apr 15 233 245
30. K. Haverson, M. Bailey, V.R. Higgins, P.W. Bland, and C.R. Stokes Characterization of monoclonal antibodies specific for monocytes, macrophages and granulocytes from porcine peripheral blood and mucosal tissues J Immunol Methods 170 1994 233 245
31. B. Alvarez, C. Sanchez, R. Bullido, A. Marina, J. Lunney, and F. Alonso A porcine cell surface receptor identified by monoclonal antibodies to SWC3 is a member of the signal regulatory protein family and associates with protein-tyrosine phosphatase SHP-1 Tissue Antigens 55 2000 342 351
32. D. Bimczok, A. Post, T. Tschernig, and H.J. Rothkotter Phenotype and distribution of dendritic cells in the porcine small intestinal and tracheal mucosa and their spatial relationship to epithelial cells Cell Tissue Res 325 2006 461 468
33. D. Bimczok, E.N. Sowa, H. Faber-Zuschratter, R. Pabst, and H.J. Rothkotter Site-specific expression of CD11b and SIRPalpha (CD172a) on dendritic cells: implications for their migration patterns in the gut immune system Eur J Immunol 35 2005 1418 1427
34. D.M. Easton, A. Nijnik, M.L. Mayer, and R.E.W. Hancock Potential of immunomodulatory host defense peptides as novel anti-infectives Trends Biotechnol 27 10 2009 582 590
35. C.A. Siegrist The challenges of vaccine responses in early life: selected examples J Comp Pathol 137 Suppl 1 2007 S4 S9
36. G. Auray, S. Lacroix-Lamande, R. Mancassola, I. Dimier-Poisson, and F. Laurent Involvement of intestinal epithelial cells in dendritic cell recruitment during C. parvum infection Microbes Infect 9 2007 574 582
37. S. Lacroix-Lamande, R. Mancassola, M. Naciri, and F. Laurent Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection Infect Immun 70 2002 2090 2099
38. M. Lotz, D. Gutle, S. Walther, S. Menard, and C. Bogdan Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells J Exp Med 203 2006 973 984
39. S. Qin, J.B. Rottman, P. Myers, N. Kassam, and M.l. Weinblatt The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions J Clin Invest 101 1998 746 754
40. B. Moser, and P. Loetscher Lymphocyte traffic control by chemokines Nat Immunol 2 2001 123 128
41. J.W. Lillard, P.N. Boyaka, D.D. Taub, and J.R. McGhee RANTES potentiates antigen-specific mucosal immune responses J Immunol 166 2001 162 169
42. R.M. Zinkernagel Localization dose and time of antigens determine immune reactivity Semin Immunol 12 2000 163
43. H. Hemmi, O. Takeuchi, T. Kawai, S. Sato, H. Sanjo, and M. Matsumoto A toll-like receptor recognizes bacterial DNA Nature 408 2000 740 745
44. H. Hacker, H. Mischak, T. Miethke, S. Liptay, R. Schmid, and T. Sparwasser CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation EMBO J 17 1998 6230 6240
45. A.K. Yi, and A.M. Krieg Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA J Immunol 161 1998 4493 4497